Home

Repaste ziarist Comerciant bta sau nmp22 markeri pret neadormit Cheie rigla

Prognostic urinary biomarkers for bladder cancer | Download Table
Prognostic urinary biomarkers for bladder cancer | Download Table

Point-of-care detection assay based on biomarker-imprinted polymer for  different cancers: a state-of-the-art review | SpringerLink
Point-of-care detection assay based on biomarker-imprinted polymer for different cancers: a state-of-the-art review | SpringerLink

Influencing factors on the NMP-22 urine assay: an experimental model | BMC  Urology | Full Text
Influencing factors on the NMP-22 urine assay: an experimental model | BMC Urology | Full Text

NMP 22 (marker tumoral vezică urinara) - Synevo
NMP 22 (marker tumoral vezică urinara) - Synevo

JPM | Free Full-Text | Liquid Biopsy Biomarkers in Urine: A Route towards  Molecular Diagnosis and Personalized Medicine of Bladder Cancer | HTML
JPM | Free Full-Text | Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer | HTML

Internet Scientific Publications
Internet Scientific Publications

Molecular screening for bladder cancer: progress and potential | Nature  Reviews Urology
Molecular screening for bladder cancer: progress and potential | Nature Reviews Urology

Influencing factors on the NMP-22 urine assay: an experimental model | BMC  Urology | Full Text
Influencing factors on the NMP-22 urine assay: an experimental model | BMC Urology | Full Text

A urine test for bladder cancer: available soon in primary care? - Martino  - 2020 - Trends in Urology & Men's Health - Wiley Online Library
A urine test for bladder cancer: available soon in primary care? - Martino - 2020 - Trends in Urology & Men's Health - Wiley Online Library

Bladder Cancer Markers and Recent Innovations | IntechOpen
Bladder Cancer Markers and Recent Innovations | IntechOpen

Analize medicale - Markeri tumorali | Bioclinica
Analize medicale - Markeri tumorali | Bioclinica

Sensitivity and Specificity Analysis of Urine NMP22, Cytokeratin-18, CA  19-9 and Cytology, for Diagnosing Bladder Malignancy
Sensitivity and Specificity Analysis of Urine NMP22, Cytokeratin-18, CA 19-9 and Cytology, for Diagnosing Bladder Malignancy

Development of biomarkers of genitourinary cancer using mass  spectrometry-based clinical proteomics - ScienceDirect
Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics - ScienceDirect

Tumor M2-PK: A novel urine marker of bladder cancer | PLOS ONE
Tumor M2-PK: A novel urine marker of bladder cancer | PLOS ONE

Bladder Cancer Markers and Recent Innovations | IntechOpen
Bladder Cancer Markers and Recent Innovations | IntechOpen

Use of Tumor Markers in Liver, Bladder, Cervical, Lung, and Gastric Cancers
Use of Tumor Markers in Liver, Bladder, Cervical, Lung, and Gastric Cancers

Cancers | Free Full-Text | Noninvasive Urine-Based Tests to Diagnose or  Detect Recurrence of Bladder Cancer | HTML
Cancers | Free Full-Text | Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer | HTML

Molecular screening for bladder cancer: progress and potential | Nature  Reviews Urology
Molecular screening for bladder cancer: progress and potential | Nature Reviews Urology

Internet Scientific Publications
Internet Scientific Publications

Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by  Urinary Nuclear Matrix Protein 22 and Cytology - European Urology
Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by Urinary Nuclear Matrix Protein 22 and Cytology - European Urology

Clinical Urology: Original Articles | Journal of Urology
Clinical Urology: Original Articles | Journal of Urology

Full article: Combinations of urine-based tumour markers in bladder cancer  surveillance
Full article: Combinations of urine-based tumour markers in bladder cancer surveillance

Diagnostics | Free Full-Text | Biomarkers for Bladder Cancer Diagnosis and  Surveillance: A Comprehensive Review | HTML
Diagnostics | Free Full-Text | Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review | HTML

Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by  Urinary Nuclear Matrix Protein 22 and Cytology - European Urology
Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by Urinary Nuclear Matrix Protein 22 and Cytology - European Urology

A Cost Comparison of the Diagnostic Modalities Used in the Detection of  Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria
A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by  Urinary Nuclear Matrix Protein 22 and Cytology - European Urology
Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by Urinary Nuclear Matrix Protein 22 and Cytology - European Urology